Stocks · Health care · Biological Products, (No Diagnostic Substances)

Metagenomi Therapeutics, Inc.

MGX Clue Score24
United States Fiscal year ends December CIK 0001785279 Results filed 10 Aug 2026

What the insiders did Net buying

By person

12 insiders · 30 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Novo Holdings A/S entity
10% owner
$13.03M (2)
—
+$13.03M
1,739,175
$2.05M
—
Pamela Wapnick
Chief Financial Officer
—
$41.23K (9)
−$41.23K
206,580
$243.76K
—
Brian C. Thomas
Director
—
$30.55K (3)
−$30.55K
2,510,960
$2.96M
+5.6%
Jian Irish
See Remarks
—
$26.83K (6)
−$26.83K
668,106
$788.37K
+27.1%
Laurence Reid
Director
$23.40K (2)
—
+$23.40K
20,000
$23.60K
—
Sarah B. Noonberg
Chief Medical Officer
—
$9.17K (1)
−$9.17K
109,135
$128.78K
+156.1%
Matthew Wein
See Remarks
—
$4.72K (7)
−$4.72K
126,133
$148.84K
+2,878%
Bayer Healthcare LLC entity
10% owner
—
—
—
4,050,997
$4.78M
—
Sebastian Bernales
Director
—
—
—
2,666,290
$3.15M
+938.1%
Simon Harnest
See Remarks
—
—
—
122,664
$144.74K
+10.4%
Simren Delaney
See Remarks
—
—
—
93,892
$110.79K
+8.0%
Luis Borges
Chief Scientific Officer
—
—
—
69,316
$81.79K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.